Cara Therapeutics Enters into Commercial License Agreement with Enteris BioPharma, Inc. for Peptelligence® Oral Formulation Technology

August 21, 2019

We're not around right now. But you can send us an email and we'll get back to you, asap.

Start typing and press Enter to search